-
Je něco špatně v tomto záznamu ?
Comparison of the neuroprotective effects of the newly developed oximes (K027, K048) with trimedoxime in tabun-poisoned rats
Jiří Kassa, Gabriela Kunešová
Jazyk čeština Země Česko
NLK
Free Medical Journals
od 2003 do 2013
Freely Accessible Science Journals
od 2003 do 2013
ROAD: Directory of Open Access Scholarly Resources
od 2002
- MeSH
- atropin aplikace a dávkování metabolismus terapeutické užití MeSH
- biologické markery MeSH
- experimenty na zvířatech MeSH
- financování vládou MeSH
- interpretace statistických dat MeSH
- krysa rodu rattus metabolismus MeSH
- neuroprotektivní látky aplikace a dávkování metabolismus terapeutické užití MeSH
- neurotoxiny aplikace a dávkování farmakologie toxicita MeSH
- organofosfáty škodlivé účinky MeSH
- otrava organofosfáty MeSH
- oximy aplikace a dávkování metabolismus terapeutické užití MeSH
- trimedoxim aplikace a dávkování metabolismus terapeutické užití MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus metabolismus MeSH
- zvířata MeSH
Tabun (O-ethyl-N,N-dimethyl phosphoramidocyanidate) is one of the highly toxic organophosphorus compounds misused as chemical warfare agents for military as well as terroristic purposes. It differs from other highly toxic organophosphates in its chemical structure and by the fact that the commonly used antidotes (atropine in combination with an oxime) are not able to sufficiently eliminate its acute toxic effects. The neuroprotective effects of the newly developed oximes (K027, K048) or trimedoxime in combination with atropine (atropine, K027/atropine, K048/atropine and trimedoxime/atropine mixtures) on rats poisoned with tabun at a lethal dose (270 mg/kg i.m.; 120% of LD50 value) were studied. The tabun-induced neurotoxicity was monitored using a functional observational battery and an automaticmeasurement of motor activity. The neurotoxicity of tabun was monitored at 24 hours and 7 days following tabun challenge. The results indicate that atropine alone is not able to protect rats from the lethal effects of tabun. Five non-treated tabun-poisoned rats and five tabun-poisoned rat treated with atropine alone died within 24 hours. On the other hand, atropine combined with all tested oximes allows most tabun-poisoned rats to survive within 7 days following tabun challenge. All three oximes tested combined with atropine seem to be sufficiently effective antidotes for a decrease in tabun-induced neurotoxicity in the case of lethal poisonings, although they are not able to eliminate tabun-induced neurotoxicity completely. Due to their neuroprotective effects, all the tested oximes appear to be more suitable oximes for the antidotal treatment of acute tabun exposure than the currently used oximes (pralidoxime, obidoxime, HI-6).
Citace poskytuje Crossref.org
Grant č. 0000501 MO0FVZ
Bibliografie atd.Lit.: 34
- 000
- 03961naa 2200457 a 4500
- 001
- bmc07500659
- 003
- CZ-PrNML
- 005
- 20111210120921.0
- 008
- 070813s2006 xr e cze||
- 009
- AR
- 024 7_
- $a 10.32725/jab.2006.013 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a Kassa, Jiří, $d 1956- $7 mzk2003181395
- 245 10
- $a Comparison of the neuroprotective effects of the newly developed oximes (K027, K048) with trimedoxime in tabun-poisoned rats / $c Jiří Kassa, Gabriela Kunešová
- 314 __
- $a Department of Toxicology, Faculty of Military Health Sciences, University of Defence, Hradec Králové
- 500 __
- $a Grant č. 0000501 MO0FVZ
- 504 __
- $a Lit.: 34
- 520 9_
- $a Tabun (O-ethyl-N,N-dimethyl phosphoramidocyanidate) is one of the highly toxic organophosphorus compounds misused as chemical warfare agents for military as well as terroristic purposes. It differs from other highly toxic organophosphates in its chemical structure and by the fact that the commonly used antidotes (atropine in combination with an oxime) are not able to sufficiently eliminate its acute toxic effects. The neuroprotective effects of the newly developed oximes (K027, K048) or trimedoxime in combination with atropine (atropine, K027/atropine, K048/atropine and trimedoxime/atropine mixtures) on rats poisoned with tabun at a lethal dose (270 mg/kg i.m.; 120% of LD50 value) were studied. The tabun-induced neurotoxicity was monitored using a functional observational battery and an automaticmeasurement of motor activity. The neurotoxicity of tabun was monitored at 24 hours and 7 days following tabun challenge. The results indicate that atropine alone is not able to protect rats from the lethal effects of tabun. Five non-treated tabun-poisoned rats and five tabun-poisoned rat treated with atropine alone died within 24 hours. On the other hand, atropine combined with all tested oximes allows most tabun-poisoned rats to survive within 7 days following tabun challenge. All three oximes tested combined with atropine seem to be sufficiently effective antidotes for a decrease in tabun-induced neurotoxicity in the case of lethal poisonings, although they are not able to eliminate tabun-induced neurotoxicity completely. Due to their neuroprotective effects, all the tested oximes appear to be more suitable oximes for the antidotal treatment of acute tabun exposure than the currently used oximes (pralidoxime, obidoxime, HI-6).
- 650 _2
- $a neuroprotektivní látky $x aplikace a dávkování $x metabolismus $x terapeutické užití $7 D018696
- 650 _2
- $a oximy $x aplikace a dávkování $x metabolismus $x terapeutické užití $7 D010091
- 650 _2
- $a trimedoxim $x aplikace a dávkování $x metabolismus $x terapeutické užití $7 D014289
- 650 _2
- $a organofosfáty $x škodlivé účinky $7 D010755
- 650 _2
- $a krysa rodu Rattus $x metabolismus $7 D051381
- 650 _2
- $a atropin $x aplikace a dávkování $x metabolismus $x terapeutické užití $7 D001285
- 650 _2
- $a neurotoxiny $x aplikace a dávkování $x farmakologie $x toxicita $7 D009498
- 650 _2
- $a experimenty na zvířatech $7 D032761
- 650 _2
- $a interpretace statistických dat $7 D003627
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a financování vládou $7 D005380
- 650 _2
- $a otrava organofosfáty $7 D062025
- 700 1_
- $a Krejčová, Gabriela $7 xx0035227
- 773 0_
- $w MED00012667 $t Journal of applied biomedicine $g Roč. 4, č. 3 (2006), s. 123-134 $x 1214-021X
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2006/03/03.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 1
- 990 __
- $a 20070813090340 $b ABA008
- 991 __
- $a 20110509102736 $b ABA008
- 999 __
- $a ok $b bmc $g 616272 $s 468704
- BAS __
- $a 3
- BMC __
- $a 2006 $b 4 $c 3 $d 123-134 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $a 2007-7/mkjb